Prevalence of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica

Seminars in Arthritis and Rheumatism

Volumn 45, Issue 3, 2015, Pages 328-333

  Narváez, Javier ^a   Estrada, Paula ^a   López Vives, Laura ^a   Ricse, Milagros ^a   Zacarías, Andrea ^a   Heredia, Sergi ^a   Gómez Vaquero, Carmen ^a   Nolla, Joan M ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Giant cell arteritis; Ischemic complications; Polymyalgia rheumatica

Indexed keywords

METHYLPREDNISOLONE; PREDNISONE;

ADULT; AGED; ANTERIOR ISCHEMIC OPTIC NEUROPATHY; AORTITIS; ARTICLE; AXILLARY ARTERY; CEREBROVASCULAR ACCIDENT; CLAUDICATION; CLINICAL ARTICLE; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GIANT CELL ARTERITIS; HUMAN; ISCHEMIA; LOW DRUG DOSE; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; RHEUMATIC POLYMYALGIA; SUBCLAVIAN ARTERY; TRANSIENT ISCHEMIC ATTACK; TRANSITIONAL BLINDNESS; VISUAL IMPAIRMENT; COMPLICATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; GIANT CELL ARTERITIS; HUMANS; ISCHEMIA; MIDDLE AGED; POLYMYALGIA RHEUMATICA; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 84955672435     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2015.06.009     Document Type: Article

References (53)

1. Gonzalez Gay M.A., Vazquez Rodriguez T.R., Lopez Diaz M.J., Miranda Filloy J.A., González Juanetey C., Martin J., et al. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum 2009, 61:1454-1612.
2. Salvarani C., Pipitone N., Versari A., Hunder G.G. Clinical features of polymyalgia rheumatica and giant cell arteritis. Nat Rev Rheumatol 2012, 8:509-521.
3. Salvarani C., Cantini F., Hunder G.G. Polymyalgia rheumatica and giant-cell arteritis. Lancet 2008, 372:234-245.
4. Weyand C.M., Goronzy J.J. Giant cell arteritis and polymyalgia rheumatica. N Engl J Med 2014, 371:50-57.
5. Gonzalez Gay M.A. Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions. Semin Arthritis Rheum 2004, 33:289-293.
6. Gonzalez-Gay M.A., Barros S., Lopez-Diaz M.J., Garcia-Porrua C., Sanchez-Andrade A., Llorca J. Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine 2005, 84:277-290.
7. Hernández-Rodríguez J., Font C., García-Martínez A., Espígol-Frigolé G., Sanmartí R., Cañete J.D., et al. Development of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica: study of a series of 100 patients. Medicine 2007, 86:233-241.
8. Sorensen S., Lorenzen I. Giant-cell arteritis, temporal arteritis and polymyalgia rheumatica. A retrospective study of 63 patients. Acta Med Scand 1977, 201:207-213.
9. Spiera H., Davison S. Long-term follow-up of polymyalgia rheumatica. Mt Sinai J Med 1978, 45:225-229.
10. Spiera H., Davison S. Treatment of polymyalgia rheumatica. Arthritis Rheum 1982, 25:120.
11. Behn A.R., Perera T., Myles A.B. Polymyalgia rheumatica and corticosteroids: how much for how long?. Ann Rheum Dis 1983, 42:374-378.
12. Delecoeuillerie G., Joly P., Cohen de Lara A., Paolaggi J.B. Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients). Ann Rheum Dis 1988, 47:733-739.
13. Chakravarty K., Pountain G., Merry P., Byron M., Hazleman B., Scott D.G. A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis. J Rheumatol 1995, 22:1694-1697.
14. Bahlas S., Ramos-Remus C., Davis P. Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis. J Rheumatol 1998, 25:99-104.
15. Jones J.G., Hazleman B.L. Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis 1981, 40:1-5.
16. Ayoub W.T., Franklin C.M., Torretti D. Polymyalgia rheumatica. Duration of therapy and long-term outcome. Am J Med 1985, 79:309-315.
17. Rodriguez-Valverde V., Sarabia J.M., González-Gay M.A., Figueroa M., Armona J., Blanco R., et al. Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica. Am J Med 1997, 102:331-336.
18. Hunder G.G., Bloch D.A., Michel B.A., Stevens M.B., Arend W.P., Calabrese L.H., et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990, 33:1122-1128.
19. Healey L.A. Long-term follow-up of polymyalgia rheumatica: evidence for synovitis. Semin Arthritis Rheum 1984, 13:322-328.
20. González-Gay M.A., Garcia-Porrua C., Salvarani C., Olivieri I., Hunder G.G. The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain. J Rheumatol 2000, 27:2179-2184.
21. Dixon A.S., Beardwell C., Kay A., Wanka J., Wong Y.T. Polymyalgia rheumatica and temporal arteritis. Ann Rheum Dis 1966, 25:203-208.
22. Hamrin B. Polymyalgia arteritica. Acta Med Scand 1972, 533(Suppl):1-131.
23. Fauchald P., Rygvold O., Oystese B. Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings. Ann Intern Med 1972, 77:845-852.
24. Hunder G.G., Allen G.L. The relationship between polymyalgia rheumatica and giant cell arteritis. Geriatrics 1973, 28:134-142.
25. Bengtsson B.A., Malmvall B.E. The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications. Arthritis Rheum 1981, 24:899-904.
26. Boesen P., Sørensen S.F. Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county. A prospective investigation, 1982-1985. Arthritis Rheum 1987, 30:294-299.
27. Franzén P., Sutinen S., von Knorring J. Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984-1988. J Rheumatol 1992, 19:273-276.
28. Mertens J.C., Willemsen G., Van Saase J.L., Bolk J.H., Dijkmans B.A. Polymyalgia rheumatica and temporal arteritis: a retrospective study of 111 patients. Clin Rheumatol 1995, 14:650-655.
29. Myklebust G., Gran J.T. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol 1996, 35:1161-1168.
30. Stammler F., Ysermann M., Mohr W., Kuhn C., Goethe S. Value of color-coded duplex ultrasound in patients with polymyalgia rheumatica without signs of temporal arteritis. Dtsch Med Wochenschr 2000, 125:1250-1256.
31. Cantini F., Niccoli L., Storri L., Nannini C., Olivieri I., Padula A., et al. Are polymyalgia rheumatica and giant cell arteritis the same disease?. Semin Arthritis Rheum 2004, 33:294-301.
32. González-Gay M.A., García-Porrúa C., Rivas M.J., Rodriguez-Ledo P., Llorca J. Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period. Ann Rheum Dis 2001, 60:367-371.
33. Schmidt W.A., Gromnica-Ihle E. Incidence of temporal arteritis in patients with polymyalgia rheumatica: a prospective study using colour Doppler ultrasonography of the temporal arteries. Rheumatology 2002, 41:46-52.
34. Salvarani C., Silingardi M., Ghirarduzzi A., Lo Scocco G., Macchioni P., Bajocchi G., et al. Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis?. Ann Intern Med 2002, 137:232-238.
35. Chuang T.Y., Hunder G.G., Ilstrup D.M., Kurland L.T. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 1982, 97:672-680.
36. Narváez J., Nolla-Solé J.M., Clavaguera M.T., Valverde-García J., Roig-Escofet D. Longterm therapy in polymyalgia rheumatica: effect of coexistent temporal arteritis. J Rheumatol 1999, 26:1945-1952.
37. Smeeth L., Cook C., Hall A.J. Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001. Ann Rheum Dis 2006, 65:1093-1098.
38. González-Gay M.A., García-Porrua C., Amor-Dorado J.C., Llorca J. Giant cell arteritis without clinically evidente vascular involvement in a defined population. Arthritis Rheum 2004, 51:274-277.
39. Armona J., Rodríguez-Valverde V., González-Gay M.A., Figueroa M., Fernández-Sueiro J.L., Blanco R., et al. Giant cell arteritis. A study of 191 patients. Med Clin(Barc) 1995, 105:734-737.
40. Martinez-Taboada V.M., Alvarez L., Ruiz Soto M., Marin-Vidalled M.J., Lopez-Hoyos M. Giant cell arteritis and polymyalgia rheumatica: role of cytokines in the pathogenesis and implications for treatment. Cytokine 2008, 44:207-220.
41. Weyand C.M., Goronzy J.J. Immune mechanisms in medium and large-vessel vasculitis. Nat Rev Rheumatol 2013, 9:731-740.
42. Weyand C.M., Hicok K.C., Hunder G.G., Goronzy J.J. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med 1994, 121:484-491.
43. Weyand C.M. The Dunlop-Dottridge Lecture: the pathogenesis of giant cell arteritis. J Rheumatol 2000, 27:517-522.
44. Weyand C.M., Younge B.R., Goronzy J.J. IFN-γand IL-17: the two faces of T-cell pathology in giant cell arteritis. Curr Opin Rheumatol 2011, 23:43-49.
45. Blockmans D., De Ceuninck L., Vanderschueren S., Knockaert D., Mortelmans L., Bobbaers H. Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients. Rheumatology 2007, 46:672-677.
46. Cimmino M.A., Zampogna G., Parodi M. Is FDG-PET useful in the evaluation of steroid-resistant PMR patients?. Rheumatology 2008, 47:926-927.
47. Muratore F., Pazzola G., Pipitone N., Boiardi L., Salvarani C. Large-vessel involvement in giant cell arteritis and polymyalgia rheumatica. Clin Exp Rheumatol 2014, 32(3 Suppl. 82):S106-S111.
48. Muratore F., Kermani T.A., Crowson C.S., Green A.B., Salvarani C., Matteson E.L., et al. Large-vessel giant cell arteritis: a cohort study. Rheumatology (Oxford) 2015, 54:463-470.
49. Rynes R.I., Mika P., Bartholomew L.E. Development of giant cell (temporal) arteritis in a patient 'adequately' treated for polymyalgia reumática. Ann Rheum Dis 1977, 36:88-90.
50. Papadakis M.A., Schwartz N.D. Temporal arteritis after normalization of erythrocyte sedimentation rate in polymyalgia rheumatica. Arch Intern Med 1986, 146:2283-2284.
51. González-Gay M.A., García-Porrúa C., Vázquez-Caruncho M. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica. J Rheumatol 1998, 25:1750-1755.
52. Schmidt W.A., Kraft H.E., Vorpahl K., Völker L., Gromnica-Ihle E.J. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 1997, 337:1336-1342.
53. González-Gay M.A., Pina T. Giant cell arteritis and polymyalgia rheumatica: an update. Curr Rheumatol Rep 2015, 17:480.